BEGIN:VCALENDAR
PRODID:-//Pixl8//Eventfolio//EN
VERSION:2.0
X-WR-TIMEZONE:Europe/Berlin
CALSCALE:GREGORIAN
METHOD:PUBLISH
CLASS:PUBLIC
BEGIN:VTIMEZONE
TZID:Europe/Berlin
LAST-MODIFIED:20260306T231828Z
TZURL:https://www.tzurl.org/zoneinfo-outlook/Europe/Berlin
X-LIC-LOCATION:Europe/Berlin
BEGIN:DAYLIGHT
TZNAME:CEST
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
DTSTART:19700329T020000
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=-1SU
END:DAYLIGHT
BEGIN:STANDARD
TZNAME:CET
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
DTSTART:19701025T030000
RRULE:FREQ=YEARLY;BYMONTH=10;BYDAY=-1SU
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20241126T090000
DTEND;TZID=Europe/Berlin:20241126T170000
DTSTAMP:20260411T052420Z
UID:{3E2A281B-35B8-484E-A62EB5F1D38D409D}
LOCATION:Online
SUMMARY:Market Access ATMPs/Gene Therapeutics
DESCRIPTION:Topics included:\n
 &#8226 Current legal and political framework in Germany and the EU\n
 &#8226 Integration of an ATMP into the statutory health insurance reimbursement 2024/25\n
 &#8226 Gene/Cell Therapies from the Perspective : Health Insurance, Hospital, Industry\n
 &#8226 Quality requirements for the application of ATMPs\n
 &#8226 Challenges of the EU HTA\n
 \n
 Event details: https://www.lisah.org/events/market-access-atmps-gene-therapeutics.html
PRIORITY:1
END:VEVENT
END:VCALENDAR